SCHEMBL27865111

SCHEMBL27865111

O=CC(CBr)c1ccc(Oc2cccc(C(=O)CBr)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERCC5 P28715 1/20 0.45
▸ FEN1 P39748 1/20 0.45
▸ TNKS O95271 1/20 0.43
▸ PARP15 Q460N3 1/20 0.43
▸ PARP14 Q460N5 1/20 0.43
▸ PARP10 Q53GL7 1/20 0.43
▸ TNKS2 Q9H2K2 1/20 0.43
▸ PARP2 Q9UGN5 1/20 0.43
▸ AKR1C3 P42330 1/20 0.42
▸ GSK3B P49841 3/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ MAPT P10636 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ PTPN1 P18031 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ KMO O15229 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27881404 0.87 GSK3B (0.49) ERCC5FEN1PARP15PARP14PARP10
SCHEMBL19339679 0.83 ERCC5 (0.48) ERCC5FEN1TNKSPARP15PARP14
SCHEMBL27865108 0.82 ERCC5 (0.47) ERCC5FEN1TNKSPARP15PARP14
SCHEMBL203505 0.81 TNKS (0.58) ERCC5FEN1TNKSPARP15PARP14
SCHEMBL5312318 0.79 ERCC5 (0.67) ERCC5FEN1TNKSPARP15PARP14
SCHEMBL27865128 0.78 GSK3B (0.50) GSK3BHDAC8PTPN1
SCHEMBL695598 0.76 GSK3B (0.43) ERCC5FEN1TNKSPARP15PARP14
SCHEMBL753074 0.72 GSK3B (0.50) ERCC5FEN1PARP15PARP14PARP10
SCHEMBL1542192 0.69 GSK3B (0.53) GSK3BMAPTPTPN1NPC1POLB
SCHEMBL29440418 0.69 GSK3B (0.53) GSK3BMAPTPTPN1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596936-A Antiviral compounds GILEAD SCIENCES INC 2012-07-18 — — CN disclosed
Send feedback